Cargando…
Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing
PURPOSE: Drug development is becoming increasingly expensive and time consuming. Drug repurposing is one potential solution to accelerate drug discovery. However, limited research exists on the use of electronic health record (EHR) data for drug repurposing, and most published studies have been cond...
Autores principales: | Wu, Yonghui, Warner, Jeremy L., Wang, Liwei, Jiang, Min, Xu, Jun, Chen, Qingxia, Nian, Hui, Dai, Qi, Du, Xianglin, Yang, Ping, Denny, Joshua C., Liu, Hongfang, Xu, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693869/ https://www.ncbi.nlm.nih.gov/pubmed/31141421 http://dx.doi.org/10.1200/CCI.19.00001 |
Ejemplares similares
-
Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality
por: Xu, Hua, et al.
Publicado: (2015) -
Computational drug repurposing based on electronic health records: a scoping review
por: Zong, Nansu, et al.
Publicado: (2022) -
Drug Repurposing: An Effective Tool in Modern Drug Discovery
por: Kulkarni, V. S., et al.
Publicado: (2023) -
Cancer based pharmacogenomics network supported with scientific evidences: from the view of drug repurposing
por: Wang, Liwei, et al.
Publicado: (2015) -
Drug repurposing: An effective strategy to accelerate contemporary drug discovery
por: Zhan, Peng, et al.
Publicado: (2022)